Literature DB >> 11867001

Chronic Fatigue Syndrome and Herpesviruses: the Fading Evidence.

Norberto E Soto1, Stephen E Straus.   

Abstract

Herpesviruses, in particular Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human herpesvirus 6 (HHV-6), have, for the past two decades, come under considerable scrutiny as aetiological agents of chronic fatigue syndrome (CFS). However, virological findings of herpesviruses in CFS have not been consistent between different studies, and the unusual patterns of serological responses to EBV, CMV and HHV-6 have not been specific for CFS, being observed also in asymptomatic individuals. In addition, patients with symptomatology suggestive of CFS do not appear to have an increased frequency of these herpesviruses, as detected by culture or polymerase chain reaction, compared with controls, which argues against an ongoing active herpetic infection. Studies have also shown that the presumable elevation of antibody titres to EBV, CMV or HHV-6 in CFS are not observed only with these viruses, but also with other organisms such as herpes simplex virus and measles.

Entities:  

Year:  2000        PMID: 11867001

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  12 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

3.  Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study.

Authors:  S-Y Tsai; T-Y Yang; H-J Chen; C-S Chen; W-M Lin; W-C Shen; C-N Kuo; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

Review 4.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

5.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) in Familial Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Alexander P Sung; Jennifer J-J Tang; Michael J Guglielmo; Julie Smith-Gagen; Lucinda Bateman; Lydia Navarrete-Galvan; Doug D Redelman; Dorothy Hudig
Journal:  Fatigue       Date:  2021-02-02

7.  Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Authors:  Marta Curriu; Jorge Carrillo; Marta Massanella; Josepa Rigau; José Alegre; Jordi Puig; Ana M Garcia-Quintana; Jesus Castro-Marrero; Eugènia Negredo; Bonaventura Clotet; Cecilia Cabrera; Julià Blanco
Journal:  J Transl Med       Date:  2013-03-20       Impact factor: 5.531

8.  Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.

Authors:  Madlen Loebel; Kristin Strohschein; Carolin Giannini; Uwe Koelsch; Sandra Bauer; Cornelia Doebis; Sybill Thomas; Nadine Unterwalder; Volker von Baehr; Petra Reinke; Michael Knops; Leif G Hanitsch; Christian Meisel; Hans-Dieter Volk; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

9.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

10.  Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Svetlana Chapenko; Angelika Krumina; Inara Logina; Santa Rasa; Maksims Chistjakovs; Alina Sultanova; Ludmila Viksna; Modra Murovska
Journal:  Adv Virol       Date:  2012-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.